LDH activity was assayed using a standard spectrophotometric technique described by Koh and Choi (1987)
As GLP-1 coverage expands, payers are seeking models that deliver measurable outcomes without runaway costs
Its really a marketing problem for the drug company, Lyon says
That said, most people will pay less than the list price, thanks to insurance coverage, deals manufacturers make with health insurers, patient assistance programs, coupons, or rebates
As the article notes, these products fall outside the legal drug supply chain and are considered unlawful by manufacturers
Glusyn 600 Injection is administered as an injection by a healthcare professional